Projects
Built supplemental scouting and evaluation teams and currently provide search and evaluation for pharma and large biotech companies
Managed the strategic investment engine for a large Japanese biotech company
Provided strategic portfolio review of assets and recommendation to large biotech companies
Provided business development and licensing support for Japanese biotech companies, in particular deal prospecting and negotiation
Succeeded in helping several biotech companies obtain funding objectives
Managed out license and divestiture of assets for a large pharmaceutical client
Managed M&A transaction for a global diagnostic company
Provided strategic growth advice and due diligence support for a medium sized biotech company
Provided strategic business and investment advice for growth initiatives and licensing support for several start up biotech companies with both platform technology and products.
Provided business development and licensing support for many clinical (phase 1, 2 and 3) products for both US, Japan, EU, China and emerging marketplaces
Provided business development and licensing support for many companies with preclinical assets
Provided strategic business and investment advice and business development support for several technology platform companies from around the globe
Performed market analysis and deal valuations for many products, platform tools and technologies and diagnostics tools
Provided M&A and due diligence support to several US, EU and Pan-Pacific companies
Performed several business strategy recommendations
Developed business plans and strategic objectives for several biotech companies and start- ups
Provided risk-assessment advice for multiple European and US based VC firms
Supported fund raising exercises for several US and European based biotech companies
Supported fund raising exercises for Israeli-based biotech company
Identified new product opportunities for large pharmaceutical companies
Provided licensing support and strategic business advice to several start up theragnostic, glycomics, and proteomics companies
Provided business advice, full licensing support, due diligence and negotiation for a phase 3 product asset of a Taiwanese biotech company
Provided strategic business assessment and product repositioning for several biotech companies
Performed market and risk assessments for several biotech companies
Provided due diligence assessment for several clinical stage products
Provided market forecasting and commercial launch planning of late stage assets for several companies
Assessed deal values for various diagnostic products and tools, preclinical assets, clinical stage products and platform technologies
Provided opportunity assessment and strategic advice to investors